Ali N. Zaidi
Albert Einstein College of Medicine
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Ali N. Zaidi.
Jacc-Heart Failure | 2016
Kanwal M. Farooqi; Omar Saeed; Ali N. Zaidi; Javier Sanz; James C. Nielsen; Daphne T. Hsu; Ulrich P. Jorde
As the population of adults with congenital heart disease continues to grow, so does the number of these patients with heart failure. Ventricular assist devices are underutilized in adults with congenital heart disease due to their complex anatomic arrangements and physiology. Advanced imaging techniques that may increase the utilization of mechanical circulatory support in this population must be explored. Three-dimensional printing offers individualized structural models that would enable pre-surgical planning of cannula and device placement in adults with congenital cardiac disease and heart failure who are candidates for such therapies. We present a review of relevant cardiac anomalies, cases in which such models could be utilized, and some background on the cost and procedure associated with this process.
International Journal of Cardiology | 2017
Pedro A. Villablanca; David Briston; Josep Rodés-Cabau; David F. Briceno; Gaurav Rao; Mohammed Aljoudi; Aman M. Shah; Divyanshu Mohananey; Tanush Gupta; Mohammed Makkiya; Harish Ramakrishna; Mario J. Garcia; Robert H. Pass; Giles J. Peek; Ali N. Zaidi
BACKGROUNDnSecundum atrial septal defects (ASDs) are treated by surgical closure (SC) or transcatheter device closure (TCC). Due to a scarcity of data directly comparing these approaches, it remains unclear which is superior. This meta-analysis compares the clinical outcomes of the two treatment options.nnnMETHODSnA literature search was performed in MEDLINE, Embase, PubMed, Google Search, and Cochrane databases for studies directly comparing SC and TCC of ASDs. Outcomes studied were major and minor acute complications, all-cause mortality, residual shunt, reinterventions, and length of stay (LOS). Relative risk (RR), difference in mean (DM) and 95% confidence intervals (CI) were calculated using the Mantel-Haenszel method with a fixed effect model. In cases of heterogeneity (defined as I2>25%), random effect models were used. Sensitivity and meta-regression analyses were performed for each outcome.nnnRESULTSnOf the 1742 manuscripts screened, 26 observational studies fulfilled the inclusion criteria (total n=14,559 patients). TCC was superior to SC for the following outcomes: all-cause mortality (RR, 0.66; 95% CI 0.64-0.99), total complications (RR, 0.48; 95% CI 0.35-0.65), major complications (RR, 0.57; 95% CI 0.40-0.81), minor complications (RR, 0.35; 95% CI 0.23-0.53), and LOS (DM, -2.92; 95% CI -3.25 to (-2.58)). Residual shunts were more common with TCC (RR, 3.35; 95% CI 1.72-6.51). No difference was observed regarding the need of reintervention (RR, 1.45; 95% CI 0.60-3.51). Meta-regression analysis showed that older age increases the risk of death and complications in patients undergoing TCC.nnnCONCLUSIONSnThough both approaches are effective, TCC is associated with lower mortality, complications, and LOS while SC has a lower rate of residual shunting.
American Journal of Cardiology | 2016
David A. Briston; Elisa A. Bradley; Aarthi Sabanayagam; Ali N. Zaidi
More adults than children with congenital heart disease (CHD) are alive today. Few studies have evaluated adult congenital heart disease (ACHD) health care utilization in the United States. Data from the National Inpatient Sample from 2002 to 2012, using International Classification of Diseases, Ninth Revision, codes for moderate and complex CHD were analyzed. Hospital discharges, total billed and reimbursed amounts, length of stay, and gender/age disparities were evaluated. There was an increase in CHD discharges (moderate CHD: 4,742 vs 6,545; severe CHD: 807 vs 1,115) and total billed and reimbursed dollar amounts across all CHD (billed:
European Journal of Obstetrics & Gynecology and Reproductive Biology | 2016
Margaret Fuchs; Ali N. Zaidi; Justin Rose; Tracey Sisk; Curt J. Daniels; Elisa A. Bradley
2.7 vs
Progress in Cardiovascular Diseases | 2018
W. Aaron Kay; Tabitha G. Moe; Blair Suter; Andrea Tennancour; Alice Chan; Richard A. Krasuski; Ali N. Zaidi
7.0 billion, 155% increase; reimbursed:
Birth defects research | 2017
Kristin Sommerhalter; Tabassum Z. Insaf; Tugba Akkaya-Hocagil; Claire McGarry; Sherry L. Farr; Karrie F. Downing; George K. Lui; Ali N. Zaidi; Alissa R. Van Zutphen
1.3 vs
Clinical Imaging | 2016
Gopi K. Nayak; Francisco J. Contreras; Jeffrey M. Levsky; Ali N. Zaidi; Nadine F. Choueiter; Linda B. Haramati
2.3 billion, 99% increase) and in the ACHD subgroup (billed:
Cardiovascular Innovations and Applications | 2018
Ali N. Zaidi; W. Aaron Kay
543 million vs
Journal of the American College of Cardiology | 2015
Aarthi Sabanayagam; Ali N. Zaidi
1.5 billion, 178% increase; reimbursed:
Journal of the American College of Cardiology | 2015
Pedro Villablanca Spinetto; Robert H. Pass; Giles J. Peek; Mohammed Algodi; Charanjit S. Rihal; Jorge R. Alegria; David F. Briceno; Ali N. Zaidi
221 vs